| Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | Blood | 2008 | 2.5K |
| Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases | Journal of Oral and Maxillofacial Surgery | 2004 | 1.5K |
| Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia | Blood | 2002 | 407 |
| Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions | Transfusion | 2002 | 252 |
| Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck | Clinical Cancer Research | 2005 | 201 |
| American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update | Australian Endodontic Journal | 2009 | 194 |
| Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry | Pediatric Blood and Cancer | 2006 | 148 |
| Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805 | Clinical Cancer Research | 2005 | 118 |
| Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia | Leukemia | 2002 | 113 |
| Osteogenic sarcoma associated with Diamond-Blackfan anemia: a report from the Diamond-Blackfan Anemia Registry | The American Journal of Pediatric Hematology/oncology | 2001 | 98 |
| Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13 | Journal of Clinical Oncology | 2005 | 87 |
| Chronic lymphocytic leukemia (CLL)-Then and now | American Journal of Hematology | 2016 | 83 |
| The Diamond Blackfan Anemia Registry: tool for investigating the epidemiology and biology of Diamond-Blackfan anemia | The American Journal of Pediatric Hematology/oncology | 2001 | 82 |
| Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection | Aids | 2001 | 81 |
| Pulmonary manifestations of sickle cell disease | Postgraduate Medical Journal | 2003 | 80 |
| Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia | Clinical Lymphoma and Myeloma | 2004 | 79 |
| Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management | Annual Review of Medicine | 2009 | 73 |
| Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia | Cancer | 2006 | 72 |
| Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia | Leukemia | 2009 | 70 |
| Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry | Bone Marrow Transplantation | 2001 | 70 |
| Gemcitabine-induced pulmonary toxicity: case report and review of the literature | American Journal of Clinical Oncology: Cancer Clinical Trials | 2002 | 66 |
| Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer | Carcinogenesis | 2010 | 65 |
| A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study | Gynecologic Oncology | 2003 | 64 |
| Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA | Oncogene | 2001 | 64 |
| Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia | Seminars in Oncology | 1998 | 64 |
